Likewise, in CRC, the YAP/GLUT3 axis could activate the metabolic reprogramming of CRC cells to promote tumor metastasis, indicating that YAP can regulate tumor malignancy and glucose metabolism in CRC 48. This evidence concerns the gene YAP1 and colorectal carcinoma.